13F reference period
Q2 2026
Security Snapshot
Inventiva S.A. - Ordinary Shares, nominal value Euro 0.01 per share (IVA) Institutional Ownership
CUSIP: 46124U107
13F Institutional Holders and Ownership History from Q3 2020 to Q3 2026
Institutions Reporting
88
Shares (Excl. Options)
84.64M
Full value: 84,640,508 · shares · 30 Jun 2026Price
$3.78
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, nominal value Euro 0.01 per share
- Symbol
- IVA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 84,640,508
- Total 13F value
- $319,469,971
- Portfolio coverage rank
- 0%
- Share change
- +34,631,994
- Value change
- +$127,767,919
- Number of holders
- 88
- Shares outstanding
- 237,753,373
- SEC-reported price per share
- $3.69
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- IVA - Inventiva S.A. - Ordinary Shares, nominal value Euro 0.01 per share is tracked under CUSIP 46124U107.
- 88 institutions reported positions in Q2 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 65 to 88 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$290.38M
Full value: $290,384,522 · USD · 31 Mar 2026.$319.47M
Full value: $319,469,971 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 88 institutions filings for Q2 2026.
Security key
46124U107
13F reference period
Q2 2026
13F holders
88
13D/G owners
10
CIK / CUSIP context first
Open Q2 2026 holders
IVA full holder history
Inventiva S.A. SEC filings
Inventiva S.A. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 46124U107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
IVA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I | 8.6% | +20% | $108,981,346 | +$64,487,273 | 19,086,050 | +145% | Sofinnova Partners SAS, a French corporation | 31 Dec 2025 |
| Andera Partners | 6.7% | -12% | $58,779,766 | +$6,697,350 | 15,929,476 | +13% | Andera Partners | 30 Sep 2026 |
| Invus Global Management, LLC | 11% | +35% | $49,037,031 | +$24,518,517 | 14,814,813 | +100% | Invus Public Equities, L.P. | 30 Jun 2025 |
| Samsara BioCapital, L.P. | 7.4% | +25% | $56,191,805 | +$22,319,746 | 13,540,194 | +66% | Srinivas Akkaraju | 17 Nov 2025 |
| BIOTECHNOLOGY VALUE FUND L P | 5% | -18% | $39,714,931 | +$4,251,111 | 9,569,863 | +12% | BVF PARTNERS L P/IL | 17 Nov 2025 |
| New Enterprise Associates 17, L.P. | 4.9% | -18% | $57,827,646 | +$6,303,642 | 9,372,390 | +12% | New Enterprise Associates 17, L.P. | 30 Mar 2026 |
| Deep Track Capital, LP | 3.8% | -38% | $42,902,558 | -$21,276,849 | 7,800,465 | -33% | Deep Track Capital, LP | 31 Mar 2026 |
| Yiheng Capital Management, L.P. | 5.5% | -36% | $43,962,416 | +$18,899,084 | 7,597,148 | +75% | Yiheng Capital Partners, L.P. | 30 Sep 2025 |
| PERCEPTIVE ADVISORS LLC | 5% | -14% | $42,246,764 | +$10,098,434 | 7,300,666 | +31% | Perceptive Advisors LLC | 30 Sep 2025 |
| Broqua Pierre | 4.3% | $15,365,625 | 4,097,500 | Pierre Broqua | 31 Dec 2024 |
As of 30 Jun 2026,
88
institutional investors reported holding
shares of
Inventiva S.A. - Ordinary Shares, nominal value Euro 0.01 per share (IVA).
This represents
36%
of the company’s total
outstanding shares.
84.64M
Full value: 84,640,508 · shares · 30 Jun 2026237.75M
Full value: 237,753,373 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
28%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Caligan Partners LP | 3.4% | 8,163,191 | +64% | 1.5% | $30,856,862 |
| SAMSARA BIOCAPITAL, LLC | 2.7% | 6,314,805 | +22% | 2% | $23,869,963 |
| Paradigm Biocapital Advisors LP | 1.7% | 4,000,000 | 0% | 0.28% | $15,120,000 |
| ANDERA PARTNERS | 1.5% | 3,633,181 | +100% | 6.7% | $13,733,424 |
| ADAR1 Capital Management, LLC | 1.5% | 3,606,656 | +66% | 0.65% | $13,633,160 |
| MILLENNIUM MANAGEMENT LLC | 1.5% | 3,512,174 | +18% | 0.01% | $13,276,018 |
| Nantahala Capital Management, LLC | 1.1% | 2,686,393 | 0.61% | $10,154,566 | |
| Trails Edge Capital Partners, LP | 1.1% | 2,657,997 | 0% | 1.6% | $10,047,228 |
| FRANKLIN RESOURCES INC | 1.1% | 2,642,611 | +7.4% | 0% | $9,989,070 |
| Squadron Capital Management LLC | 1% | 2,435,000 | +355% | 3.2% | $9,204,300 |
| Woodline Partners LP | 0.98% | 2,323,149 | 0.03% | $8,781,503 | |
| Aberdeen Group plc | 0.97% | 2,307,773 | 0.01% | $8,723,382 | |
| UBS Group AG | 0.97% | 2,305,192 | -0.58% | 0% | $8,713,626 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.84% | 2,003,782 | +36% | 0.15% | $7,574,296 |
| Patient Square Capital LP | 0.83% | 1,967,171 | 1.2% | $7,435,906 | |
| NEXTBio Capital Management LP | 0.75% | 1,787,984 | +34% | 3.1% | $6,758,580 |
| CITADEL ADVISORS LLC | 0.75% | 1,784,566 | +2648% | 0% | $6,745,659 |
| AMERIPRISE FINANCIAL INC | 0.71% | 1,697,148 | +101% | 0% | $6,415,219 |
| Point72 Asset Management, L.P. | 0.71% | 1,683,012 | +76% | 0.01% | $6,361,785 |
| Integral Health Asset Management, LLC | 0.64% | 1,520,000 | +280% | 0.24% | $5,745,600 |
| Yu Fan | 0.63% | 1,500,000 | 0% | 5.3% | $5,670,000 |
| NEA Management Company, LLC | 0.62% | 1,462,586 | 0% | 0.35% | $5,528,575 |
| STEMPOINT CAPITAL LP | 0.6% | 1,426,320 | 0.93% | $5,391,490 | |
| JPMORGAN CHASE & CO | 0.55% | 1,309,100 | 0% | $4,647,305 | |
| Propel Bio Management, LLC | 0.54% | 1,281,212 | +77% | 2.5% | $4,842,981 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
25
Headline period
Q2 2026
Rows shown
1-25 of 25
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 5,071,997 | $18,684,782 | -$126,908 | $3.69 | 13 |
| 2026 Q2 | 84,640,508 | $319,469,971 | +$127,767,919 | $3.78 | 88 |
| 2026 Q1 | 52,362,514 | $290,384,522 | +$33,010,984 | $5.55 | 65 |
| 2025 Q4 | 46,711,433 | $217,189,873 | +$153,107,827 | $4.65 | 53 |
| 2025 Q3 | 5,106,787 | $29,415,940 | +$1,094,859 | $5.79 | 15 |
| 2025 Q2 | 4,928,159 | $15,667,628 | +$214,859 | $3.19 | 12 |
| 2025 Q1 | 4,860,363 | $12,214,319 | -$1,721,340 | $2.94 | 8 |
| 2024 Q4 | 5,447,098 | $11,663,912 | +$1,275,982 | $2.14 | 7 |
| 2024 Q3 | 4,851,351 | $9,059,439 | -$1,414 | $1.86 | 7 |
| 2024 Q2 | 4,845,553 | $14,461,203 | -$19,438 | $2.99 | 7 |
| 2024 Q1 | 4,849,836 | $17,555,978 | -$52,773 | $3.62 | 8 |
| 2023 Q4 | 4,860,874 | $21,917,529 | +$26,077 | $4.52 | 8 |
| 2023 Q3 | 4,855,354 | $20,589,732 | +$102,187 | $4.20 | 7 |
| 2023 Q2 | 4,830,074 | $19,513,567 | -$1,019,078 | $4.04 | 8 |
| 2023 Q1 | 5,129,875 | $18,275,932 | +$1,089,878 | $3.64 | 8 |
| 2022 Q4 | 4,812,252 | $21,919,774 | -$19,722,477 | $4.44 | 6 |
| 2022 Q3 | 8,933,248 | $33,067,000 | -$1,003,809 | $3.86 | 7 |
| 2022 Q2 | 9,109,429 | $51,761,000 | +$29,343,302 | $5.77 | 10 |
| 2022 Q1 | 3,934,328 | $45,020,000 | +$2,060,118 | $11.40 | 9 |
| 2021 Q4 | 3,755,787 | $51,299,000 | +$608,002 | $13.66 | 10 |
| 2021 Q3 | 3,708,525 | $52,500,000 | +$30,368,738 | $14.16 | 11 |
| 2021 Q2 | 1,564,469 | $21,328,000 | -$848,745 | $13.58 | 14 |
| 2021 Q1 | 1,623,116 | $23,833,940 | -$15,643,566 | $14.69 | 13 |
| 2020 Q4 | 2,733,996 | $39,206,000 | -$22,116,536 | $14.50 | 15 |
| 2020 Q3 | 4,021,314 | $47,498,000 | +$47,498,000 | $11.81 | 17 |